| | |
| Texas abortion fight to reignite in second special session Monday, Jul 01, 2013 12:50 PM PDT | Top |
| Hitler's food taster feared death with every morsel Monday, Jul 01, 2013 12:01 PM PDT By Michelle Martin BERLIN (Reuters) - Margot Woelk spent the last few years of World War Two eating lavish meals and fearing that every mouthful could mean death. The former food taster for Adolf Hitler was served a plate of food and forced to eat it between 11 and 12 every morning for most of the last 2-1/2 years of the Nazi German leader's life. If she did not fall ill, the food was packed into boxes and taken to Hitler at the Wolf's Lair, a military headquarters located deep in woodland, in what is today northeastern Poland. ... Full Story | Top |
| CORRECTED-Obamacare 1.0: States brace for Web barrage when reform goes live Monday, Jul 01, 2013 11:58 AM PDT | Top |
| FDA rejects Merck insomnia drug, seeks lower-dose Monday, Jul 01, 2013 10:17 AM PDT (Reuters) - U.S. health regulators have rejected Merck & Co's new insomnia drug application but opened the door to approving a lower-dose version of the medication, the company said on Monday. Merck said it received a complete response letter from the U.S. Food and Drug Administration saying that the agency could consider a 10 milligram starting dose of suvorexant for most patients, but that the company would have to have that dosage ready before it could be approved. ... Full Story | Top |
| South Africa's Mandela still 'critical but stable' Monday, Jul 01, 2013 08:54 AM PDT | Top |
| Insmed's lung infection drug fares no better than rival, shares fall Monday, Jul 01, 2013 07:38 AM PDT (Reuters) - Insmed Inc's experimental lung infection drug fared no better than a competing drug developed by Novartis AG in a lung function test, sending shares in the company down 27 percent in pre-market trading. Insmed's drug, Arikace, was being tested as a treatment for a bacterial lung infection that often affects cystic fibrosis patients. Insmed said in a statement that the trial met its main goal of showing that Arikace was not inferior to the competing drug. ... Full Story | Top |
| Collapsible hampers pose eye risk for kids: doctors Monday, Jul 01, 2013 07:21 AM PDT By Genevra Pittman NEW YORK (Reuters Health) - Collapsible laundry hampers with wire supports may pose a risk to children's eyes, according to researchers who saw two related injuries within a year, both requiring surgery. Such hampers have an embedded stiff wire spring, which can be dangerous if the cloth frays and the wire becomes exposed, researchers said. "Parents should receive a warning of the risks of these hampers," Dr. Iris Kassem from the University of Illinois at Chicago and her colleagues wrote Monday in Pediatrics. ... Full Story | Top |
| Blasting heat forecast for U.S. Western states Monday, Jul 01, 2013 06:46 AM PDT | Top |
| FDA rejects Merck's insomnia drug Monday, Jul 01, 2013 05:24 AM PDT (Reuters) - Merck & Co Inc said the U.S. Food and Drug Administration rejected the company's experimental insomnia drug, citing safety issues. In a complete response letter to the company, the FDA said the safety data of the drug do not support approval, and advised that lower doses of the medicine should be made available before an approval. The efficacy of the drug, suvorexant, was established at doses of 10 mg to 40 mg in adults, the FDA said, adding that 10 mg should be the starting dose for most patients. (Reporting by Esha Dey in Bangalore) Full Story | Top |
| WHO wants HIV patients treated sooner to save lives, halt spread Monday, Jul 01, 2013 01:42 AM PDT By Kate Kelland LONDON (Reuters) - Doctors could save three million more lives worldwide by 2025 if they offer AIDS drugs to people with HIV much sooner after they test positive for the virus, the World Health Organisation said on Sunday. While better access to cheap generic AIDS drugs means many more people are now getting treatment, health workers, particularly in poor countries with limited health budgets, currently tend to wait until the infection has progressed. But in new guidelines aimed at controlling and eventually reducing the global AIDS epidemic, the U.N. ... Full Story | Top |
| Teva says cleared of wrongdoing after man's death in France Monday, Jul 01, 2013 01:30 AM PDT | Top |
| Differences between the sexes stretches to fitness formulas Sunday, Jun 30, 2013 11:06 PM PDT | Top |
| Ohio governor signs budget including tax cut, anti-abortion provision Sunday, Jun 30, 2013 08:08 PM PDT | Top |
| Onyx explores possible sale after rejecting Amgen offer Sunday, Jun 30, 2013 05:15 PM PDT By Ryan Vlastelica and Olivia Oran NEW YORK (Reuters) - Cancer drugmaker Onyx Pharmaceuticals Inc said on Sunday it rejected a roughly $10 billion takeover offer from larger biotechnology company Amgen Inc as too low but still is considering selling itself. Onyx said Amgen's cash offer of $120 a share, which represents a premium of about 38 percent to the company's Friday closing price, "significantly undervalued" its prospects. Deutsche Bank analyst Robin Karnauskas estimated Onyx's value to a merger partner at up to $148 a share. ... Full Story | Top |
| Western United States swelters amid deadly heat Sunday, Jun 30, 2013 04:48 PM PDT | Top |
|

No comments:
Post a Comment